Cargando…
Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial
INTRODUCTION: Early treatment of rheumatoid arthritis (RA) has been shown to retard the development of joint damage for a period of up to 5 years. The aim of this study was to evaluate the radiologic progression beyond that time in patients with early RA initially treated with a combination of three...
Autores principales: | Rantalaiho, Vappu, Korpela, Markku, Laasonen, Leena, Kautiainen, Hannu, Järvenpää, Salme, Hannonen, Pekka, Leirisalo-Repo, Marjatta, Blåfield, Harri, Puolakka, Kari, Karjalainen, Anna, Möttönen, Timo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911916/ https://www.ncbi.nlm.nih.gov/pubmed/20576092 http://dx.doi.org/10.1186/ar3060 |
Ejemplares similares
-
First-year drug therapy of new-onset rheumatoid and undifferentiated arthritis: a nationwide register-based study
por: Muilu, Paula, et al.
Publicado: (2020) -
Baseline JAK phosphorylation profile of peripheral blood leukocytes, studied by whole blood phosphospecific flow cytometry, is associated with 1-year treatment response in early rheumatoid arthritis
por: Kuuliala, Krista, et al.
Publicado: (2017) -
STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid Arthritis
por: Kuuliala, Krista, et al.
Publicado: (2016) -
Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial
por: Väänänen, Tuija, et al.
Publicado: (2017) -
Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
por: Paalanen, Kirsi, et al.
Publicado: (2020)